๐ฐ Jonas Petersen News
Jonas Petersen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jonas Petersen. Real-time updates on events, politics, business and more.
May 19, 2024
By University of Copenhagen - Faculty of Health and Medical Sciences May 19, 2024
May 16, 2024
A groundbreaking paper in Nature describes a promising new therapy for obesity that leads to greater weight loss in mice than existing medications. The approach smuggles molecules into the brain's appetite centre and affects the brain's neuroplasticity.
May 16, 2024
A groundbreaking paper in Nature describes a promising new therapy for obesity that leads to greater weight loss in mice than existing medications.
September 18, 2023
"If it wasn't for Novo Nordisk there wouldn't have been any growth in the first six months of the year," the chief economist at Danske Bank told AFP.
September 13, 2023
Without the exporting boom of Novo Nordisk, now the highest valued company in Europe, the Scandinavian countryโs economy would be in the red
September 9, 2023
National statistics data show that Denmarkโs GDP experienced a surge of 1.7% year-on-year during the first half of this year.
September 8, 2023
And it looks like their availability will only increase
September 7, 2023
COPENHAGEN โ Massive demand for diabetes and weight loss drugs made by Danish pharmaceutical group Novo Nordisk have turned it into Europe's most valuable company, giving Denmark's economy a major makeover."If it wasn't for Novo Nordisk there wouldn't have been any growth" in the first six months of the year, Danske Bank chief economist Las Olsen told AFP.The company's
September 6, 2023
Massive demand for diabetes and weight loss drugs made by Danish pharmaceutical group Novo Nordisk have turned it into Europes most valuable company, giving Denmarks economy a major makeover.
September 6, 2023
Massive demand for diabetes and weight loss drugs made by Danish pharmaceutical group Novo Nordisk have turned it into Europe's most valuable company, giving Denmark's economy a major makeover."If it wasn't for Novo Nordisk there wouldn't have been any growth" in the first six months of the year, Danske Bank chief economist Las Olsen told AFP. The company's earnings have ballooned thanks to two in-demand prescription medications: type 2 diabetes drug Ozempic --...